Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
30
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
12
users have commented on this narrative
26
users have followed this narrative
12 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
7
users have commented on this narrative
25
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Clorox
AN
AnalystLowTarget
Consensus Narrative from 17 Analysts
Consumer Shifts And Rising Compliance Costs Will Erode Margins
Key Takeaways Heavy reliance on traditional formulas and slow innovation expose Clorox to shifting consumer preferences and increased competition from private labels and digital-native brands. Stricter regulations, rising environmental compliance costs, and persistent supply chain pressures threaten profitability and long-term margin stability.
View narrative
US$115.00
FV
4.6% overvalued
intrinsic discount
-1.51%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
15 days ago
author updated this narrative
News
AN
AnalystLowTarget
Consensus Narrative from 9 Analysts
Print Decline And Facebook Dominance Will Challenge Future Outlook
Key Takeaways Declining print ad revenue and challenges monetizing digital audiences threaten overall revenue and long-term subscription growth. Rising costs and increased digital competition are expected to erode profitability and weaken News Corp's premium pricing power.
View narrative
US$28.00
FV
8.9% overvalued
intrinsic discount
2.08%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
15 days ago
author updated this narrative
Eli Lilly
AN
AnalystLowTarget
Consensus Narrative from 27 Analysts
Drug Pricing Reforms And Patent Expiry Will Constrain Outcomes
Key Takeaways Potential drug pricing reforms and wider pricing parity efforts threaten future profitability and limit pricing power, especially for high-profile obesity and diabetes products. Heavy revenue reliance on a few core drugs and rising R&D demands increase vulnerability to competition, patent loss, and adverse data, risking future growth and margins.
View narrative
US$650.00
FV
9.5% overvalued
intrinsic discount
13.46%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
15 days ago
author updated this narrative
Five Star Bancorp
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Northern California Expansion And Diversification Will Create Lasting Value
Key Takeaways Strategic market expansion and client-focused deposit growth are boosting revenue opportunities and strengthening financial margins. Investments in digital efficiency and loan portfolio diversification support stable, long-term earnings and reduce risk exposure.
View narrative
US$35.25
FV
7.5% undervalued
intrinsic discount
21.92%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
4 days ago
author updated this narrative
JTEKT India
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Expansion In C-EPS And CVJ Will Strengthen Future Product Portfolio
Key Takeaways Favorable policy and infrastructure developments forecast positive revenue impact, supported by localization and new export opportunities. Expansion plans and advanced product improvements aim at increased capacity and profitability through higher technological value and cost efficiency.
View narrative
₹151.00
FV
12.8% undervalued
intrinsic discount
9.14%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
3 days ago
author updated this narrative
SRG Global
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Acquisition Of Diona Will Strengthen Position In Water Security And Energy Transition
Key Takeaways Strategic acquisition and market positioning will bolster long-term growth in water security and energy transition sectors, enhancing revenue stability. Capital-light model and strong cash position improve margins and financial flexibility, enabling growth investments and shareholder returns.
View narrative
AU$1.95
FV
0.8% undervalued
intrinsic discount
7.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
Updated
narrative
DarioHealth
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Integrated Digital Health And AI Will Expand Chronic Care Markets
Key Takeaways Shifting focus to high-margin recurring revenue and expanding into digital chronic care markets, with strong early traction in new platform segments. AI-driven operational efficiencies and signed large health plan deals set the stage for improved profitability and accelerated revenue growth in coming years.
View narrative
US$1.96
FV
71.0% undervalued
intrinsic discount
18.28%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
9 days ago
author updated this narrative
Atlas Energy Solutions
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Permian Shale Trends Will Secure A Resilient Logistics Future
Key Takeaways Shrinking competition and integrated logistics are boosting Atlas' pricing power, asset utilization, and long-term contract stability with Permian energy customers. Diversification into power and tech sectors, combined with rising sand intensity, supports predictable, cyclicality-resistant revenue growth and expanding margins.
View narrative
US$15.18
FV
22.1% undervalued
intrinsic discount
2.62%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
32
users have followed this narrative
4 days ago
author updated this narrative
Thyrocare Technologies
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Franchise Expansion And PharmEasy Partnerships Will Secure Future Success
Key Takeaways Rapid network expansion and broader service offerings are increasing test volumes, driving sustained revenue and margin growth through operating leverage and higher-value tests. Focus on quality accreditation, technology, and digital partnerships strengthens market position, improves efficiency, and supports ongoing growth in demand and profitability.
View narrative
₹1.36k
FV
6.8% undervalued
intrinsic discount
19.34%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
3 days ago
author updated this narrative
Value any company in seconds
Popular companies